Impact of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) on cancer treatment outcomes: An overview about well-established and recently emerging clinical data
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference196 articles.
1. Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now?;Aapro;Support. Care Cancer,2010
2. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours;Aapro;Eur. J. Cancer,2011
3. Biosimilar filgrastim initiation in patients enrolled in the MONITOR G-CSF observational study relative to EORTC guidelines;Aapro;Eur. Soc. Med. Oncol.,2012
4. Neutropenia in a patient treated with ipilimumab (anti-CTLA-4 antibody);Akhtari;J. Immunother.,2009
5. A contemporary update on rates and management of toxicities of targeted therapies for metastatic renal cell carcinoma;Alasker;Cancer Treat. Rev.,2013
Cited by 82 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prevalence and risks of intravenous chemotherapy-induced severe neutropenia in solid cancers: a multicenter retrospective cohort study on real-life data;Supportive Care in Cancer;2024-09-13
2. A dual-radiomics model for overall survival prediction in early-stage NSCLC patient using pre-treatment CT images;Frontiers in Oncology;2024-08-14
3. Effectiveness of biosimilar pegfilgrastim in patients with lymphoma after high-dose chemotherapy and autologous stem cell transplantation: a real-life study;Frontiers in Hematology;2024-07-25
4. Cost-effectiveness analysis of granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced febrile neutropenia in patients with breast cancer in Taiwan;PLOS ONE;2024-06-10
5. The potential impact of exercise upon symptom burden in adolescents and young adults undergoing cancer treatment;Supportive Care in Cancer;2024-04-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3